Dr. Frank Longo, Stanford University professor of neurology and PharmatrophiX co-founder, joins ‘Squawk Box’ to discuss the company’s new Alzheimer’s drug LM11A-31, how the new drug approaches treatment differently from existing Alzheimer’s therapies, and more.